Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease
NCT04736966
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Alcoholic Liver Disease
Interventions
DRUG:
Guselkumab 30mg
DRUG:
Guselkumab 70mg
DRUG:
Guselkumab 100mg
Sponsor
University of California, San Diego